Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing.
Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Péoc'h M, Istier L, Chalabreysse P, Muller C, Alberti L, Bringuier PP, Scoazec JY, Schott AM, Bergeron C, Cellier D, Blay JY, Ray-Coquard I. Ducimetière F, et al. Among authors: alberti l. PLoS One. 2011;6(8):e20294. doi: 10.1371/journal.pone.0020294. Epub 2011 Aug 3. PLoS One. 2011. PMID: 21826194 Free PMC article.
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region].
Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Isaac S, Claret-Tournier C, Suignard Y, Salameire D, Cellier D, Alberti L, Bringuier PP, Blay JY, Ray-Coquard I. Ducimetière F, et al. Among authors: alberti l. Bull Cancer. 2010 Jun;97(6):629-41. doi: 10.1684/bdc.2010.1117. Bull Cancer. 2010. PMID: 20504759 Review. French.
Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study.
Neuville A, Ranchère-Vince D, Dei Tos AP, Montesco MC, Hostein I, Toffolatti L, Chibon F, Pissaloux D, Alberti L, Decouvelaere AV, Albert S, Rossi CR, Blay JY, Coindre JM. Neuville A, et al. Among authors: alberti l. Am J Surg Pathol. 2013 Aug;37(8):1259-68. doi: 10.1097/PAS.0b013e31828f51b9. Am J Surg Pathol. 2013. PMID: 23774173
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution.
Fayette J, Boyle H, Chabaud S, Favier B, Engel C, Cassier P, Thiesse P, Méeus P, Sunyach MP, Vaz G, Ray-Coquard I, Ranchère D, Decouvelaere AV, Alberti L, Pérol D, Blay JY. Fayette J, et al. Among authors: alberti l. Anticancer Drugs. 2010 Jan;21(1):113-9. doi: 10.1097/CAD.0b013e328333057b. Anticancer Drugs. 2010. PMID: 19887935 Clinical Trial.
Therapeutic pipeline for soft-tissue sarcoma.
Cassier PA, Labidi-Galy SI, Heudel P, Dutour A, Méeus P, Chelghoum M, Alberti L, Ray-Coquard I, Blay JY. Cassier PA, et al. Among authors: alberti l. Expert Opin Pharmacother. 2011 Nov;12(16):2479-91. doi: 10.1517/14656566.2011.604633. Epub 2011 Sep 13. Expert Opin Pharmacother. 2011. PMID: 21913865 Review.
Prediction of desmoid tumor progression using miRNA expression profiling.
Dufresne A, Paturel M, Alberti L, Philippon H, Duc A, Decouvelaere AV, Cassier P, Blay JY. Dufresne A, et al. Among authors: alberti l. Cancer Sci. 2015 May;106(5):650-5. doi: 10.1111/cas.12640. Epub 2015 Apr 6. Cancer Sci. 2015. PMID: 25707497 Free PMC article. Clinical Trial.
Targeted cancer therapies.
Blay JY, Le Cesne A, Alberti L, Ray-Coquart I. Blay JY, et al. Among authors: alberti l. Bull Cancer. 2005 Feb;92(2):E13-8. Bull Cancer. 2005. PMID: 15749638 Free article. Review.
309 results